First Trust Advisors’s Atea Pharmaceuticals AVIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-203,566
Closed -$761K 2354
2023
Q2
$761K Buy
203,566
+1,781
+0.9% +$6.66K ﹤0.01% 2039
2023
Q1
$676K Buy
201,785
+15,387
+8% +$51.5K ﹤0.01% 2060
2022
Q4
$897K Sell
186,398
-12,881
-6% -$62K ﹤0.01% 1995
2022
Q3
$1.13M Buy
+199,279
New +$1.13M ﹤0.01% 1945